development of a Self-efficacy Scale for Self-management of skin reacton induced by cancer chemotherapy

development of a Self-efficacy Scale for Self-management of skin reacton induced by cancer chemotherapy - development of a Self-efficacy Scale for Self-management of skin reacton

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023501

Enrollment

130

Registered

2016-08-08

Start date

2016-08-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer, gastroenterological cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients going to treat with anti-cancer agents and molecular targeted drugs that cause skin reaction in the high frequency as a side effect, Patients who can speak/read/write Japanese, Patients who thier physician determines that the possible cooperation of the survey, Patinets who agree with participation in the study

Exclusion criteria

Exclusion criteria: Severe physical symptoms of the disease and treatment, Severe psychiatric symptoms such as anxiety and depression, Decline in cognitive function, Life expectancy within a few weeks

Design outcomes

Primary

Measure	Time frame
The scale of Self-efficacy for Self-management of skin reaction	—

Secondary

Measure	Time frame
QOL scale for skin disease; Skindex29, Hospital Anxiety and Depression Scale Japanese Version, General Self-Efficacy Scale	—

Countries

Japan

Contacts

Public ContactNoriko Tamura

Keio University Faculty of Nursing and Medical Care

norry@sfc.keio.ac.jp03-5363-2189

Outcome results